Abstract: The present invention provides carbohydrate encapsulated nanoparticles. In particular, the present invention provides metallic nanoparticles (e.g. gold nanoparticles) that are encapsulated in biologically important carbohydrate molecules, such as sugars, sugar derivatives, P-blood group antigens and analogues thereof. The present invention also provides methods of employing these carbohydrate encapsulated nanoparticles in diagnostic and therapeutic applications.
Type:
Grant
Filed:
February 19, 2004
Date of Patent:
April 13, 2010
Assignees:
Academia Sinica, National Taiwan University, National Taiwan Normal University
Abstract: A method for producing a deposition product includes providing a deposition solution having a pH below 7 and comprising an aqueous solution of a silver salt comprised of silver ions and an oxidizing agent. The silver salt is comprised of silver nitrate and has a concentration in the deposition solution between about 1 and 20 grams per liter. The oxidizing agent is comprised of a persulfate and has a concentration in the deposition solution between about 1 and 50 grams per liter. The method further includes producing the deposition product by facilitating a chemical reaction between the silver ions and the oxidizing agent while maintaining the deposition solution at a temperature of between about 2 and 40 degrees Celsius. The deposition product consists essentially of at least one oxidized silver species, and is comprised of a compound having the formula Ag7O8X, where X is an anion.
Abstract: The present invention provides a method for increasing analgesic potency of a bimodally-acting opioid agonist in a subject, by inhibiting GM1-ganglioside in nociceptive neurons. The present invention further provides a method for treating pain in a subject in need of treatment thereof. Also provided in the present invention is a method for treating chronic pain in a subject in need of treatment thereof. Additionally, the present invention provides a method for treating tolerance to or an addiction to a bimodally-acting opioid agonist in a subject in need of treatment thereof. Finally, the present invention provides a pharmaceutical composition of analgesic agents and a pharmaceutically-acceptable carrier.
Abstract: A process of producing a concentrated liquid biocide formulation is described. Mixed together are (a) bromine and (b) an aqueous solution of alkali metal salt of sulfamic acid having a pH of at least about 12, in amounts such that (i) the active bromine content of the solution is at least about 100,000 ppm (wt/wt), and (ii) the atom ratio of nitrogen to active bromine from (a) and (b) is greater than 1. A continuous process for producing the concentrated liquid biocide composition is provided. This process comprises continuously feeding into mixing apparatus (i) bromine and (ii) an aqueous solution of alkali metal salt of sulfamic acid; the desired product is withdrawn from the mixing apparatus at a rate sufficient to enable the continuous feeding to be maintained. Also described are methods for disinfecting surfaces and for sanitizing bodies of water using a single-feed, bromine-based biocide. These methods use concentrated liquid biocide compositions comprising biocidally active bromine as the biocide.
Type:
Application
Filed:
June 8, 2009
Publication date:
October 1, 2009
Applicant:
ALBEMARLE CORPORATION
Inventors:
Robert M. Moore, JR., Christopher J. Nalepa
Abstract: A composition that generates and releases a biocidal solution comprising at least chlorine dioxide and hypobromous acid is presented. The composition comprises reactants capable of in-situ generation of chlorine dioxide and hypobromous acid, and a gelling agent that slows the rate of dissolution of the reactants, thereby increasing yield and providing a sustained release of biocidal solution. The chemical reaction is triggered when the reactants are contacted by a main solvent (e.g., water). Upon being exposed to the main solvent, the gelling agent forms a gelatinous structure that creates a chamber within the composition enclosing some of the reactants such that the in-situ generation takes place in the chamber. The gelatinous structure contributes to the high yield of the target product (e.g., chlorine dioxide) and its controlled release.
Abstract: The present invention is a composition, preferably a cleanser, comprising sulfur, sodium sulfacetamide and at least one emulsifier with a low HLB number. These compositions are stable and may include moisturizers and humectants. Use of these compositions include treatments for acne rosacea, acne vulgaris and other skin disorders.
Abstract: The present invention provides compositions and methods for improving stool quality of a puppy by adjusting the balance of metabolizable cations to metabolizable anions consumed by the puppy.
Abstract: Self-assembly of nanoparticles at the interface between two fluids, and methods to control such self-assembly process, e.g., the surface density of particles assembling at the interface; to utilize the assembled nanoparticles and their ligands in fabrication of capsules, where the elastic properties of the capsules can be varied from soft to tough; to develop capsules with well-defined porosities for ultimate use as delivery systems; and to develop chemistries whereby multiple ligands or ligands with multiple functionalities can be attached to the nanoparticles to promote the interfacial segregation and assembly of the nanoparticles. Certain embodiments use cadmium selenide (CdSe) nanoparticles, since the photoluminescence of the particles provides a convenient means by which the spatial location and organization of the particles can be probed. However, the systems and methodologies presented here are general and can, with suitable modification of the chemistries, be adapted to any type of nanoparticle.
Type:
Grant
Filed:
January 8, 2004
Date of Patent:
December 30, 2008
Assignee:
University of Massachusetts
Inventors:
Todd S. Emrick, Thomas P. Russell, Anthony Dinsmore, Habib Skaff, Yao Lin
Abstract: The present invention relates to compositions for the treatment of pilosebaceous gland inflammations, especially of the hair follicle and its appendages, in particular of Acne Vulgaris and Folliculitis, comprising as active ingredient AIF or chemical compounds which finally release AIF, or combinations of aluminum and fluoride salts which finally release AIF. AIF in accordance with the present invention relates to Aluminum fluoride (Aluminum Trifluoride; Aluminum Fluoride), CAS No 7784-18-1, EINECS No. 232-051-1, having an empirical formula of AIF3. Said compositions have, inter alia, pharmaceutical, cosmetic or quasi-cosmetic properties. The present invention also relates to the use of said compositions in said treatment, and to methods for the treatment of pilosebaceous gland inflammations with said compositions.
Abstract: An antimicrobial vulcanized rubber article that includes at least one rubber component; and an antimicrobial agent selected from the group consisting of zinc pyrithione, zinc dimethyldithiocarbamate, and chlorhexidine base.
Type:
Application
Filed:
April 6, 2007
Publication date:
October 9, 2008
Inventors:
Anders H. Johansson, Bonnie Jean Swayze, Susan D. Clark, John W. Ellis, Charles R. Hodges
Abstract: This invention relates to novel colonic purgative compositions in a solid dosage form, comprising at least one purgative and at least one soluble, or soluble, nonfermentable binder, such as polyethylene glycol. Further, this invention relates to methods of using the colonic purgative compositions. The present compositions and methods are designed to improve patient tolerance and compliance, while at the same time improving the quality of bowel cleansing. The formulations and methods of this invention are particularly useful to cleanse the bowel prior to diagnostic and surgical procedures and can also be employed in lower dosages as a laxative to promote elimination and/or to relieve constipation.
Type:
Application
Filed:
March 13, 2008
Publication date:
September 4, 2008
Applicant:
Salix Pharmaceuticals, Inc.
Inventors:
Stephen Skiendzielewski, Martin Rose, Ngoc Do
Abstract: The present invention provides novel stable, liquid compositions comprising chalcogenides or salts thereof. These compositions may be used for a variety of purposes, including the treatment and prevention of ischemic or hypoxic injury, as well as in the preservation of biological matter.
Type:
Application
Filed:
January 31, 2008
Publication date:
August 21, 2008
Applicant:
IKARIA HOLDINGS
Inventors:
Kevin J. Tomaselli, Paul A. Hill, Thomas L. Deckwerth, Edward Wintner, Csaba Szabo
Abstract: The present invention provides novel stable, liquid compositions comprising chalcogenides or salts thereof. These compositions may be used for a variety of purposes, including the treatment and prevention of ischemic or hypoxic injury, as well as in the preservation of biological matter.
Type:
Application
Filed:
October 5, 2007
Publication date:
August 7, 2008
Applicant:
IKARIA, INC.
Inventors:
Kevin J. Tomaselli, Paul A. Hill, Thomas L. Deckwerth, Edward Wintner, Csaba Szabo
Abstract: The present invention is directed to a method for treating the foot of an animal, including treatment of infectious diseases of the foot of an animal. Among the various aspects of the invention is provided a method of contacting a foot of an animal with an antimicrobial composition comprising water, sulfuric acid, ammonium sulfate or sodium sulfate, and, optionally, an antimicrobial metal. Also provided is a method of rotational treatment wherein a foot of an animal is contacted with a series of antimicrobial composition with and without an antimicrobial metal component.
Type:
Application
Filed:
January 18, 2008
Publication date:
July 10, 2008
Inventors:
Stephen P. Mixon, Dennis M. Smithyman, Rosemary Smithyman
Abstract: A patient with a disease associated with a receptor having a cysteine residue is treated with a thiol reactive agent. The diseases include neurodegenerative diseases. Diseases characterized by skeletal muscle atrophy are also treated.
Abstract: A kraft paper sheet contains and/or is coated with a fungi growth-inhibiting agent that causes the kraft paper sheet to be fungi growth resistant. The kraft paper sheet alone or as part of a layered sheet material is used as a central field portion of facings for various faced building insulation assemblies. The facings, as part of an insulation assembly, are fungi growth resistant; may be perforated to provide the facing with a selected water vapor permeance; and/or may include a bonding layer, such as a heat activated bonding layer, that bonds the facing to an insulation layer of the assembly.
Type:
Grant
Filed:
September 28, 2006
Date of Patent:
June 3, 2008
Assignee:
Johns Manville
Inventors:
Ralph Michael Fay, Anthony E. Moore, Timothy D. Logsdon, Blake Boyd Bogrett
Abstract: Embodiments relate generally to topical compositions useful for treating or preventing a variety of cosmetic conditions and dermatological disorders, where the composition comprises an oxidative pharmaceutical drug and an antioxidant polyhydroxy acid or polyhydroxy lactone. The polyhydroxy acid or polyhydroxy lactone improves the cutaneous effects of the drug. The embodiments further relate to the treatment of a variety of cosmetic conditions and dermatological disorders comprising administering to a subject an effective amount of the composition and to methods of making the compositions.
Abstract: A method for treating rosacea in a patient comprising administering to a patient suffering from rosacea a first topical composition comprising at least one sulfacetamide or a derivative thereof and at least one sunscreen, wherein the administration of said first composition provides a more effective treatment of said rosacea in comparison to treatment of rosacea achieved by administration of a second topical composition comprising metronidazole.
Abstract: A personal care composition that includes a personal care ingredient and semiconductor nanocrystals. A method of protecting at least a portion of a body against ultraviolet radiation by applying a personal care composition is also provided.
Abstract: The invention includes convenient methods of preparing: (1) highly concentrated liquid bromine-containing biocidal solutions, (2) highly concentrated mixed halogen liquid bromine and chlorine-containing biocidal solutions, and (3) high-activity bromine-containing biocidal solids, all having excellent physical and chemical stability. One method yields solutions that have concentrations of bromine in excess of 18% as Br2 (8% as Cl2) in which the mole ratio of hydroxide ion to hydrogen ion source is at least 1.9:1. Another method employs elemental bromine in conjunction with a solid organic or inorganic halogenating agent to yield halogen solutions at concentrations greater than 22.9% as Br2 (10.2% as Cl2). This method can be performed under conditions that exceed the solubility of the active ingredient such that it crystallizes and is recovered as a hydrated or anhydrous salt in good yield.
Abstract: Methods for the production of deposition products including an oxidized metal species under both acidic and alkaline conditions, methods for the production of composite materials including a substrate and the deposition product, and products in the nature of deposition products and composite materials. The methods are particularly suited for depositing a very thin layer of a deposition product on a substrate and may be used to produce composite materials for use in many applications, including but not limited to electronics, materials engineering and medical applications. In a preferred embodiment, the metal is silver, the substrates are medical devices or components of medical devices and the deposition product includes an antimicrobially active oxidized silver species.
Abstract: A non-stoichiometric clathrate of lipid and sulfur has been shown to effectively stabilize nerve cell membranes. As such, said compound has proven useful in a variety of neuropsychiatric disorders such as, addiction, depression, autism, Tourette's syndrome, and the like.
Abstract: A method of making a poisoned stake device, the poisoned stake device and a method of using the poisoned stake device are disclosed. The method of making the poisoned stake device includes the steps of acquiring, adding, combining, curing, dispensing, filling, getting, mixing, pouring, procuring, removing, and scooping. The device is made from the method of making a poisoned stake device. The method of using the poisoned stake device includes the steps of discarding, identifying, inhibiting, obtaining, and removing so that burrowing mammal pest may be either killed or encouraged to vacate the vicinity of their burrowed hill.
Abstract: The invention relates to the use of treosulfan and/or derivatives thereof for producing a pharmaceutical composition used in the treatment of multiple sclerosis.
Type:
Grant
Filed:
August 12, 2003
Date of Patent:
June 26, 2007
Assignee:
Medac Gesellschaft fur Klinische Spezialpraparate mbH
Abstract: Described is a process of producing a concentrated liquid biocide formulation. Mixed together are (a) bromine chloride or bromine and (b) an aqueous solution of alkali metal salt of sulfamic acid having a pH of at least about 7, in amounts such that (i) the active bromine content of the solution is at least about 100,000 ppm (wt/wt), and (ii) the atom ratio of nitrogen to active bromine from (a) and (b) is greater than 1 when bromine is used and is greater than 0.93 when bromine chloride is used. Use of bromine chloride as the source of the active bromine in the process is preferred because in the resulting aqueous compositions, all of the bromine of the bromine chloride is made available as active bromine in solution. In other words, the chlorine of the bromine chloride is converted in the process to dissolved alkali metal chloride salt, thereby liberating all of the bromine in the biocidal composition as active bromine capable of providing biocidal activity.
Abstract: The invention relates to an improved and stable (i.e. color-stable and, optionally, stable with regard to its hyperforin content) extract from the overground parts of Hypericum perforatum L., to a method for the preparation thereof, and to pharmaceutical preparations and topical medicaments that contain this extract; in particular, gels for treating skin and mucous membrane irritations and disorders such as acne, atopic dermatitis, neuro-dermatitis, psoriasis, stomatitis, herpes zoster, herpes labialis (lip herpes), warts, varicella (chicken-pox), sores, burns and other bacterial and viral skin and mucous membrane infections and skin disorders that are accompanied by cell proliferation and inflammation.
Type:
Grant
Filed:
December 21, 2001
Date of Patent:
January 23, 2007
Assignee:
Dr. Willmar Schwabe GmbH & Co.
Inventors:
Egon Koch, Clemens Erdelmeier, Joachim Herrmann
Abstract: Environmentally friendly processes for prevention of qualitative deterioration and quantitative loss of plant matter and foodstuffs, during all stages of storage and handling, including pre- and post-harvest, pre- and post-planting, distribution and marketing involves the use of H2O2 compositions including Ag and at least one of Cu and Zn ions. The processes can also be used to prevent sprouting and rooting, and to promote fecundity of certain plant matter, and can also be used to eliminate or reduce quantities of harmful organisms and substances from soil, other growth media and substrates, equipment, materials water, workspaces and surfaces.
Abstract: This invention relates to a method of treating a livestock footbath solution comprising adding an alkali metal bisulfate to the solution. The invention also relates to a method of treating a livestock footbath solution comprising adding to the solution a blend of an alkali metal bisulfate and a material to treat a bacterial disease. The invention also relates to a method of treating a livestock footbath solution comprising rotating the addition to the solution of an alkali metal bisulfate and a material to treat a bacterial disease.
Abstract: A method of eradicating or at least substantially reducing biofilm on a surface in contact with water, or which comes in contact with water, which method comprises introducing into such water a concentrated aqueous biocidal composition formed from bromine chloride and an aqueous solution of an alkali metal salt of sulfamic acid, such composition having an active bromine content of at least about 100,000 ppm (wt/wt), a pH of at least about 7, and an atom ratio of nitrogen to active bromine of greater than 0.93.
Abstract: Pulmonary disorders in which the GSNO pool or glutathione pool in the lung is depleted and where reactive oxygen species in lung are increased, are treated by delivering into the lung as a gas, agent causing repletion or increase of the GSNO pool or protection against toxicity and does so independently of reaction with oxygen. Agents include ethyl nitrite, NOCl, NOBr, NOF, NOCN, N2O3, HNO, and H2S. Optionally, N-acetylcysteine, ascorbate, H2S or HNO is administered in addition to other GSNO repleting agent to potentiate the effect of said agent.
Abstract: A bactericide useful as a shelf life extender for produce and other food products. The bactericide is an aqueous solution formed from water, copper sulfate pentahydrate and a reagent, which can either be an acid or hydrogen peroxide. The bactericide is applied as a coating on the food product and is especially useful in extending the shelf life of fruits and vegetables. Other applications of the bactericide include treatment of drinking water, bacteria and algae control in pools and natural bodies of, water and as a disinfectant in cleansers.
Abstract: Sulfuryl fluoride and ovicidal gases have been found to exert a synergistic action on insect eggs, so it is possible to fumigate under sublethal conditions relative to the ovicide, and the dose of ovicidal gas can be reduced e.g. to sublethal concentrations.
Abstract: A method for reducing the production of malodor in sulfur containing dermatological compositions by adjusting the pH of the composition to between about 6.5 to about 8.1. Also, sulfur containing dermatological compositions having a pH between about 6.5 and about 8.1.
Type:
Grant
Filed:
October 29, 2002
Date of Patent:
June 14, 2005
Assignee:
Medicis Pharmaceutical Corporation
Inventors:
Jonah Shacknai, Eugene H. Gans, Ray Figureoa
Abstract: The production process comprises A) forming an acidic aqueous solution comprising alkali metal cations, bromide anions, and sulfamate anions; B) feeding into said aqueous solution a source of alkali metal cations and chlorine-containing bromide oxidant proportioned to keep the resultant aqueous medium acidic and to form an acidic product solution containing at least about 5 wt % of active bromine, and C) raising the pH of the aqueous product solution with water-soluble base to at least about 10.
Abstract: Th present invention relates to nutritional and pharmaceutical compositions. More particularly it is concerned with improving compositions which due to the presence of an efflorescent component may be unstable and prone to decomposition and/or spoilage. The problem is overcome by incorporating one or mote anhydrous compounds into the composition in an amount capable of sequestering any water which may be released from one or more water containing components. The preferred anhydrous compounds are anhydrous or calcined MgSO4 and CaO.
Abstract: A composition and method of treating severe itching by topically administering a therapeutically effective amount of colloidal sulfur suspended in a pharmaceutically acceptable carrier including a diketone.
Abstract: A foot powder includes boric acid powder and sublimed sulfur powder. In a number of embodiments, the foot powder includes about 40% to about 60% by weight of boric acid powder and about 40% to about 60% by weight of sublimed sulfur powder. In other embodiments, the ratio of boric acid powder to sublimed sulfur powder is about 1:1, that is, about 50% by weight of boric acid powder and about 50% by weight of sublimed sulfur powder. The foot powder may be used to treat foot odor and wetness.
Abstract: A method of treating laminitis in a horse is disclosed, comprising administering to the horse a naturally chelated trace mineral composition; promoting healthy skin, hair and hoof tissue. A method of reducing dietary intake is also disclosed, comprising administering to a horse in need thereof, effective amounts of a naturally chelated trace mineral composition. A method of preparing the chelated trace mineral composition from ocean seabed rock is further disclosed, as well as the chelated trace mineral composition.
Abstract: The present invention provides a pharmaceutical dosage form comprising a fill material sealed in a gelatin capsule; the fill material comprises (a) a selective COX-2 inhibitory drug of low water solubility, and (b) a sulfite compound in an amount sufficient to inhibit cross-linking of gelatin in said gelatin capsule upon storage of the dosage form in a closed container maintained at 40° C. and 75% relative humidity for a period of 6 months.
Type:
Application
Filed:
July 31, 2003
Publication date:
June 3, 2004
Inventors:
Ping Gao, Juliane M. Bauer, Gary D. Ewing, David C. Sperry
Abstract: A mineral supplement or feed for ruminant animals, especially deer, contains effective amounts of sulfur and garlic to repel insects from the animals. By inducing the repellant into the animal via ingestion of the mineral supplement or feed, disease and stress in the animals as caused by the insects is reduced.
Abstract: The invention provides a synthetic hydrated organosulfur agent, a method for producing it, and a method of using it for exterminating soil fungi. The synthetic hydrated organosulfur agent is prepared by adding starch to an inorganic hydrated sulfur agent, and sulfur is enveloped in starch in the agent. When the agent is applied to soil, microbes and pathogenic fungi (fusariums, pythiums and other various mold fungi) in soil act on the saccharides such as glucose polymerized with starch, and they are attracted by the grains of the agent. While the microbes and pathogenic fungi thus attracted them degrade the grains, they are kept in contact with the sulfur having been released from the degraded grains and are thereby killed. Not deactivated in soil, sulfur in the synthetic hydrated organosulfur agent exhibits its fungicidal activity for a long period of time.
Abstract: The is invention is directed to a composition useful for assisting in supplying a warm-blooded animal with many of its nutritional needs. More specifically, this invention is directed to a composition whereby many of the vitamins, minerals, amino acids and cofactors are suspended in a matrix which when administered to a mammal provides substantial benefit.
Abstract: A method for reducing the production of malodor in sulfur containing dermatological compositions by adjusting the pH of the composition to between about 6.5 to about 8.1. Also, sulfur containing dermatological compositions having a pH between about 6.5 and about 8.1.
Type:
Application
Filed:
October 29, 2002
Publication date:
March 25, 2004
Applicant:
MEDICIS PHARMACEUTICAL CORPORATION
Inventors:
JONAH SHACKNAI, Eugene H. Gans, Ray Figureoa
Abstract: Sulfuryl fluoride and ovicidal gases have been found to exert a synergistic action on insect eggs, so it is possible to fumigate under sublethal conditions relative to the ovicide, and the dose of ovicidal gas can be reduced e.g. to sublethal concentrations.
Abstract: The present invention relates to a biocidal composition, designed for the generation of chlorine dioxide, comprising at least one iodo-compound having at least one iodine atom and a source of chlorite ions. The molar ration of chlorite ions to iodine atoms is 2 or greater. The composition finds use in a variety of applications including methods of cleaning, sanitizing, deodorizing, and disinfecting various surfaces.
Type:
Grant
Filed:
September 19, 2000
Date of Patent:
December 16, 2003
Assignee:
Ecolab Inc.
Inventors:
Robert D. P. Hei, David Daniel McSherry, Kim R. Smith, Keith E. Olson
Abstract: Active bromine-containing solutions are produced and stabilized by reacting bromate and bromide salt solutions with an amino-complexing agent, such as sulfamic acid or sulfamate salt. The reaction is performed at a pH of less than 1 to create a complexed hypobromate. The pH of the active bromine-containing solution is raised to between 4 and 10 by adding an alkali to improve stability. Moreover, the solution is maintained below 30° C. during the alkali addition to retain bromine equivalent activity.
Type:
Grant
Filed:
April 16, 2001
Date of Patent:
December 9, 2003
Assignee:
United States Filter Corporation
Inventors:
Vadim Zolotarsky, Irina A. Ivanter, Tamara Oustinskaya
Abstract: Described is a process of producing a concentrated liquid biocide formulation. Mixed together are (a) bromine chloride or bromine and (b) an aqueous solution of alkali metal salt of sulfamic acid having a pH of at least about 7, in amounts such that (i) the active bromine content of the solution is at least about 100,000 ppm (wt/wt), and (ii) the atom ratio of nitrogen to active bromine from (a) and (b) is greater than 1 when bromine is used and is greater than 0.93 when bromine chloride is used. Use of bromine chloride as the source of the active bromine in the process is preferred because in the resulting aqueous compositions, all of the bromine of the bromine chloride is made available as active bromine in solution. In other words, the chlorine of the bromine chloride is converted in the process to dissolved alkali metal chloride salt, thereby liberating all of the bromine in the biocidal composition as active bromine capable of providing biocidal activity.
Type:
Grant
Filed:
October 9, 2001
Date of Patent:
November 25, 2003
Assignee:
Albemarle Corporation
Inventors:
Robert M. Moore, Jr., Christopher J. Nalepa
Abstract: A composition of matter and the method of making that provides a low pH acidic composition that is useful for destroying microorganisms that are undesirable and useful for destroying or reducing melanomas on human skin. The composition and method include sulfuric acid combined with distilled water and ammonium sulfate under at least 15 psi pressure in a pressurized container, all of which is heated to approximately 800° F. or more for at least 3 hours. The final cooled mixture is stabilized with 10 percent of the original mixture. The resultant composition is useful for preserving food, such as fresh fish, and for skin treatment of melanoma and as bactericides, fungicides, or viricides.